MedPath

PERFECT Project - Part 1 - Study 3

Not Applicable
Completed
Conditions
Diabetes Prevention
Obesity Prevention
Interventions
Other: Pea fibre
Other: Pea flour
Other: Pea protein
Other: Pea flour + pea protein
Other: Pea fibre + pea protein
Other: Control
Registration Number
NCT02385890
Lead Sponsor
University of Manitoba
Brief Summary

The objectives are to test the acute effects of different bagels containing pulse ingredients on: 1) post-prandial blood glucose, insulin and appetite for two hours, and 2) food intake two hours following consumption of pulse products.

The investigators hypothesize that bagels containing pulse ingredients will lead to lower blood glucose, insulin, appetite and food intake responses compared to non-pulse bagels.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Normoglycemic (<5.6 mmol/L) and normotensive (systolic blood pressure <140 mm Hg and diastolic blood pressure below < 90 mm Hg)
  • BMI of 18.5-29.9 kg/m2
Read More
Exclusion Criteria
  • Restrained eaters
  • Regularly skip breakfast
  • Smokers
  • Those who are active (organized activities or athletic training at a high intensity; ≥ 150 min per week of moderate to vigorous physical activity)
  • Those on medications that may influence study outcomes or have experienced any gastrointestinal related health conditions/surgeries over the past year.
  • Those unable to walk for an hour continuously
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Bagel with pea fibrePea fibrePea fibre
Bagel with pea flourPea flourPea flour
Bagel with pea proteinPea proteinPea protein
Bagel with pea flour + pea proteinPea flour + pea proteinPea flour + pea protein
Bagel with pea fibre + pea proteinPea fibre + pea proteinPea fibre + pea protein
Bagel controlControl100% wheat flour
Primary Outcome Measures
NameTimeMethod
Plasma Glucose and Insulin Concentrations0-200

Measured in blood using intravenous catheter at 12 time points used to calculate area under curve (AUC). Glucose will be determined by automated methods using Abbot Spectrum CCX Analyzer, and Insulin will be measured by commercially available RIA kits

Food Intakeat 120 min

Ad-libitum meal. Food consumed measured by weight

Subjective Appetite0-200 min

Motivation-to-eat VAS questionnaire used to calculate area under curve (AUC)

Secondary Outcome Measures
NameTimeMethod
Palatability of mealat 140 mins

Measured by VAS questionnaire

Physical comfort0 - 200 min

Measured by VAS questionnaire at 12 time points used to calculate area under curve (AUC)

Energy/fatigue measured by VAS questionnaire0 - 200 mins

Measured by VAS questionnaire at 12 time points, used to calculate area under curve (AUC)

Palatability of treatmentsat 5 mins

Measured by VAS questionnaire

Trial Locations

Locations (1)

Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba

🇨🇦

Winnipeg, Manitoba, Canada

© Copyright 2025. All Rights Reserved by MedPath